Coegin Pharma AB (NGM:COEGIN)
Sweden · Delayed Price · Currency is SEK 3.370
+0.030 (0.90%)
At close: Jul 9, 2026
Coegin Pharma AB Earnings Call Transcripts
Fiscal Year 2024
-
Follicopeptide, a novel hair growth peptide, is set for a Q4 2025 launch in Europe and the U.S., with production and regulatory processes on schedule. Clinical studies show over 70% efficacy, and commercialization will occur through established partners.